دورية أكاديمية
From Cardiorenal Syndrome to Chronic Cardiovascular and Kidney Disorder: A Conceptual Transition.
| العنوان: | From Cardiorenal Syndrome to Chronic Cardiovascular and Kidney Disorder: A Conceptual Transition. |
|---|---|
| المؤلفون: | Zoccali C; Renal Research Institute, New York and Institute of Molecular Biology and Genetics (Biogem), Ariano Irpino, Italy.; Associazione Ipertensione Nefrologia Trapianto Renal (IPNET), c/o Nefrologia, Grande Ospedale Metropolitano, Reggio Calabria, Italy., Mallamaci F; Nefrologia and CNR Unit, Grande Ospedale Metropolitano, Reggio Calabria, Italy., Halimi JM; Centre Hospitalier Régional Universitaire de Tours, Tours, France., Rossignol P; Inserm, Centre d'Investigations Cliniques-1433, Inserm U1116, CHRU Nancy, F-CRIN INI-CRCT, Université de Lorraine, Nancy, France.; Department of Medical Specialties-Nephrology Hemodialysis, Princess Grace Hospital, Monaco Private Hemodialysis Centre, Monaco, Monaco., Sarafidis P; Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece., De Caterina R; University of Pisa and Cardiology Division, Pisa University Hospital, Pisa, Italy., Giugliano R; Fondazione Villaserena per la Ricerca, Pescara, Italy., Zannad F; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. |
| المصدر: | Clinical journal of the American Society of Nephrology : CJASN [Clin J Am Soc Nephrol] 2024 Jun 01; Vol. 19 (6), pp. 813-820. Date of Electronic Publication: 2023 Oct 30. |
| نوع المنشور: | Journal Article; Review |
| اللغة: | English |
| بيانات الدورية: | Publisher: Wolters Kluwer Health Country of Publication: United States NLM ID: 101271570 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1555-905X (Electronic) Linking ISSN: 15559041 NLM ISO Abbreviation: Clin J Am Soc Nephrol Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: 2023- : Hagerstown, MD : Wolters Kluwer Health Original Publication: Washington, D.C. : American Society of Nephrology, c2005- |
| مواضيع طبية MeSH: | Cardio-Renal Syndrome*/physiopathology , Cardio-Renal Syndrome*/classification , Cardio-Renal Syndrome*/diagnosis , Cardio-Renal Syndrome*/epidemiology, Humans ; Cardiovascular Diseases/etiology ; Cardiovascular Diseases/physiopathology ; Cardiovascular Diseases/epidemiology ; Renal Insufficiency, Chronic/physiopathology ; Renal Insufficiency, Chronic/complications ; Renal Insufficiency, Chronic/diagnosis ; Renal Insufficiency, Chronic/epidemiology ; Disease Progression ; Kidney/physiopathology ; Risk Factors ; Terminology as Topic |
| مستخلص: | The association between cardiac and kidney dysfunction has received attention over the past two decades. A putatively unique syndrome, the cardiorenal syndrome, distinguishing five subtypes on the basis of the chronology of cardiac and kidney events, has been widely adopted. This review discusses the methodologic and practical problems inherent to the current classification of cardiorenal syndrome. The term "disorder" is more appropriate than the term "syndrome" to describe concomitant cardiovascular and kidney dysfunction and/or damage. Indeed, the term disorder designates a disruption induced by disease states to the normal function of organs or organ systems. We apply Occam's razor to the chronology-based construct to arrive at a simple definition on the basis of the coexistence of cardiovascular disease and CKD, the chronic cardiovascular-kidney disorder (CCKD). This conceptual framework builds upon the fact that cardiovascular and CKD share common risk factors and pathophysiologic mechanisms. Biological changes set in motion by kidney dysfunction accelerate cardiovascular disease progression and vice versa . Depending on various combinations of risk factors and precipitating conditions, patients with CCKD may present initially with cardiovascular disease or with hallmarks of CKD. Treatment targeting cardiovascular or kidney dysfunction may improve the outcomes of both. The portfolio of interventions targeting the kidney-cardiovascular continuum is in an expanding phase. In the medium term, applying the new omics sciences may unravel new therapeutic targets and further improve the therapy of CCKD. Trials based on cardiovascular and kidney composite end points are an attractive and growing area. Targeting pathways common to cardiovascular and kidney diseases will help prevent the adverse health effects of CCKD. (Copyright © 2023 by the American Society of Nephrology.) |
| References: | Nat Rev Nephrol. 2022 Dec;18(12):762-778. (PMID: 36064794) J Am Coll Cardiol. 2008 Nov 4;52(19):1527-39. (PMID: 19007588) Am J Med Sci. 2003 Jul;326(1):15-24. (PMID: 12861121) Lancet Diabetes Endocrinol. 2020 Nov;8(11):903-914. (PMID: 33065060) Endocr Rev. 2012 Feb;33(1):48-70. (PMID: 22240243) Environ Int. 2022 Feb;160:107085. (PMID: 35042049) Br J Clin Pharmacol. 2013 May;75(5):1202-12. (PMID: 23088367) Heart Fail Rev. 2012 Mar;17(2):177-90. (PMID: 21688186) Biomolecules. 2020 Jan 07;10(1):. (PMID: 31936109) World J Diabetes. 2021 Aug 15;12(8):1233-1247. (PMID: 34512889) Nephrol Dial Transplant. 2022 Nov 23;37(12):2386-2397. (PMID: 35438794) Eur Heart J. 2021 Dec 21;42(48):4891-4901. (PMID: 34423370) Eur Heart J. 2021 Sep 7;42(34):3227-3337. (PMID: 34458905) Heart Fail Rev. 2022 Nov;27(6):2137-2153. (PMID: 35133552) J Ren Care. 2010 May;36 Suppl 1:18-26. (PMID: 20586896) Am J Physiol Renal Physiol. 2019 May 1;316(5):F974-F985. (PMID: 30838876) Circulation. 2021 Mar 2;143(9):949-958. (PMID: 33406882) J Clin Med. 2019 Mar 28;8(4):. (PMID: 30925803) Eur Heart J. 2014 Feb;35(6):341-3. (PMID: 24126877) N Engl J Med. 2020 Oct 8;383(15):1436-1446. (PMID: 32970396) Eur Heart J. 2005 Jan;26(1):11-7. (PMID: 15615794) Nephrol Dial Transplant. 2019 Jul 1;34(7):1112-1114. (PMID: 30815678) J Am Soc Nephrol. 2004 Dec;15(12):3103-10. (PMID: 15579513) Hypertension. 2015 Jun;65(6):1331-40. (PMID: 25870193) N Engl J Med. 2004 Sep 23;351(13):1296-305. (PMID: 15385656) Kidney Int Suppl (2011). 2011 Jun;1(1):2-5. (PMID: 25028622) Int J Cardiol. 2009 Jul 10;135(3):302-7. (PMID: 18582965) Front Cardiovasc Med. 2022 May 26;9:889553. (PMID: 35694669) Eur J Heart Fail. 2020 Apr;22(4):618-628. (PMID: 32037659) Circ Heart Fail. 2019 Jun;12(6):e005875. (PMID: 31163986) Eur Heart J. 2012 Jan;33(2):176-82. (PMID: 21900289) JACC Heart Fail. 2018 Jun;6(6):489-498. (PMID: 29655829) Eur Heart J. 2003 Mar;24(5):412-20. (PMID: 12633543) N Engl J Med. 2023 Jan 12;388(2):117-127. (PMID: 36331190) N Engl J Med. 2019 Jun 13;380(24):2295-2306. (PMID: 30990260) N Engl J Med. 2015 Nov 26;373(22):2117-28. (PMID: 26378978) Sci Rep. 2021 Dec 16;11(1):24127. (PMID: 34916574) J Am Soc Nephrol. 2006 Nov;17(11):3059-66. (PMID: 17005935) Nat Rev Nephrol. 2022 May;18(5):294-306. (PMID: 35145275) Nat Rev Nephrol. 2018 Jul;14(7):442-456. (PMID: 29760448) Nat Rev Dis Primers. 2021 Jul 15;7(1):52. (PMID: 34267223) Circ Res. 2017 Mar 31;120(7):1183-1196. (PMID: 28360349) Nat Rev Mol Cell Biol. 2007 Sep;8(9):741-52. (PMID: 17717517) Nephrol Dial Transplant. 2008 Oct;23(10):3103-10. (PMID: 18503101) EBioMedicine. 2020 Jan;51:102590. (PMID: 31901868) Hypertension. 2022 Aug;79(8):1633-1643. (PMID: 35703100) Eur Heart J. 2015 Jun 14;36(23):1437-44. (PMID: 25838436) Circulation. 2010 Jun 15;121(23):2592-600. (PMID: 20547939) N Engl J Med. 2020 Dec 03;383(23):2219-2229. (PMID: 33264825) J Clin Med. 2020 Jul 23;9(8):. (PMID: 32718053) Circulation. 2019 Apr 16;139(16):e840-e878. (PMID: 30852913) Eur Heart J. 2021 Sep 21;42(36):3599-3726. (PMID: 34447992) Nat Rev Nephrol. 2013 Feb;9(2):99-111. (PMID: 23247571) Eur Heart J. 2022 Dec 21;43(48):4991-5002. (PMID: 36017745) N Engl J Med. 2014 Sep 11;371(11):993-1004. (PMID: 25176015) Circulation. 2023 Nov 14;148(20):1606-1635. (PMID: 37807924) J Hypertens. 2021 Mar 1;39(3):408-416. (PMID: 33031182) Int J Environ Res Public Health. 2018 Feb 22;15(2):. (PMID: 29470452) Lancet. 2000 May 6;355(9215):1575-81. (PMID: 10821360) Heart. 2021 Jun 11;107(13):1032-1038. (PMID: 33637556) N Engl J Med. 2012 Dec 6;367(23):2204-13. (PMID: 23121378) Ann Intern Med. 2003 Aug 19;139(4):244-52. (PMID: 12965979) AMIA Annu Symp Proc. 2003;:802. (PMID: 14728307) SAGE Open Med. 2019 Mar 21;7:2050312119835043. (PMID: 30915218) Front Cardiovasc Med. 2022 Sep 06;9:1008922. (PMID: 36148061) |
| تواريخ الأحداث: | Date Created: 20231030 Date Completed: 20240607 Latest Revision: 20240615 |
| رمز التحديث: | 20240615 |
| مُعرف محوري في PubMed: | PMC11168830 |
| DOI: | 10.2215/CJN.0000000000000361 |
| PMID: | 37902772 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 1555-905X |
|---|---|
| DOI: | 10.2215/CJN.0000000000000361 |